Regular with this, we observed that RTA 405 treatment did not increase proliferation of KRASG12D MEFs (Fig 8E)
Impact of RTA 405 on survival of WT and KRAS mutant mobile strains. A-B. LSL-KrasG12D MEFs were mock-infected or infected with adenoviral-Cre or adenoviral-EGFP for seventy two hrs. A. PCR…